1Davis J, Shubeler D, Lam W, et al. Comprehensive epigenomic profiling of matched normal and tumor lung cell lines. Lung Can-cer,2005,49(Suppl 2):S122(P-028).
2Tan E, Hsu A, Eng P, et al. Molecular profiling of lung cancers: Can it be used as clinical tool? Lung Cancer,2005,49(Suppl 2):S147(P-123) .
3Ewis A, Kondo A, Shinohara Y, et al. Occupational lung cancer: Application of microarray technology for monitoring gene expression patterns in chromate-related lung cancer. Lung Cancer,2005,49(Suppl 2):S124(P-034).
4Snead D, Dhillon D, Vohra H, et al. Genome-wide analysis of LOH by SNP microarray to demonstrate chromosome losses common to both pre-cursor lesion and invasive lung cancer. Lung Cancer,2005,49(Suppl 2):S146(P-118).
5Oscarson M. Genetic polymorphisms in the cytochrome P450 2A6 (CYP2A6) gene: implications for interindividual differences in nicotine metabolism. Drug Metab Dispos,2001,29(2):91-95.
6Thun MJ, Henley SJ, Calle EE. Tobacco use and cancer: an epidemiologic perspective for geneticists. Oncogene,2002,21(48):7307-7325.
7Benhamou S, Lee WJ, Alexandrie AK, et al. Meta- and pooled analyses of the effects of glutathione S-transferase M1 polymorphisms and smoking on lung cancer risk. Carcinogenesis,2002,23(8):1343-50. Erratum in: Carcinogenesis,2002,23(10):1771.
8Sgambato A, Campisi B, Zupa A, et al. Glutathione S-transferase (GST) polymorphisms as risk factors for cancer in a highly homogeneous population from southern Italy. Anticancer Res,2002,22(6B):3647-3652.
9Ho J, Mark J, Tsang MIK, et al. Manganese superoxide dismutase and catalase genetic polymorphisms, activity level and lung cancer risk in Chinese in Hong kong. Lung Cancer,2005,49(Suppl 2):S191(P-290).
10Felletti R, Verna A, Quaglia A, et al. Comparison of DNA adduct level in nasal mucosa lymphocytes and bronchial mucosa of cigarettes smokers and interaction with metabolic gene polymorphisms. Lung Cancer,2005,49(Suppl 2):S191(P-289).
8Htmaphrey PA,Wong AJ,Vogelstein B,et al.Amplification and expression of EGFR in human glioma xenografts.Cancer Res,1998,48:2231-2238.
9Yuan A,Yu CJ,Chen WJ,et al.Correlation of total VEGF mRNA and protein expression with histologic type,tumor angiogenesis,patient survival and timing of relapse in non-small-cell lung cancer.Int J Cancer,2000,89:475-483.
10Groeger AM,Esposito V,De Luea A,et al.Prognostic value of immunohistochemical experssion of P53,bax,Bcl-2 and Bcl-xL in resected non-small cell lung cancers[J].Histopathology,2004,44 (l):54-63.
